BioTell, Epoch Pharmaceuticals, Syngenta Participations, Hitachi Software Engineering, Nanogen, Applera, Cellomics | GenomeWeb

BioTell of Brookline, Mass., received US Patent No. 6,728,429, “Optical detection.” The patent covers waveguide-based technology to increase sensitivity of surface plasmon resonance (SPR) measurement through the use of differential detection. The enhanced sensitivity of the method enables analysis and detection of a wide range of analytes including DNA, antibodies, proteins, and other chemical compounds. These methods achieve this result by sampling the SPR response curve at more than one point.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.